|

BG-60366 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • BeiGene1

Indications

  • EGFR Mutation-Related Tumors1
  • EGFR Activating Mutation1
  • NSCLC (Non-small Cell Lung Carcinoma)1
  • NSCLC1
  • Lung Cancer1

Denver, Colorado1 trial

A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

University of Colorado

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.